Form of Proxy

WHITEHAWK THERAPEUTICS, INC.

Notes

BD Client Code:

Client Name:

Number of Shares Held in a BD Nominee Company:

No.	Proposition		For	Against	Abstain
1	DIRECTOR Anupam Dalal, M.D.
2	DIRECTOR Mohammad Hirmand, M.D.
3	DIRECTOR David Lennon, Ph.D.
4	To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the Executive Compensation section of the proxy statement.
5	To ratify the appointment of BDO USA, P.C. as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2025.